Company Update (NASDAQ:AMGN): Amgen Statement Regarding Third Point Investment

[PR Newswire] – THOUSAND OAKS, Calif., Oct. 21, 2014 /PRNewswire/ — Amgen (AMGN) issued the following statement with respect to media inquiries concerning Third Point LLC’s equity position in Amgen: Amgen maintains an . . . → Read More: Company Update (NASDAQ:AMGN): Amgen Statement Regarding Third Point Investment Similar Articles: Company Update: Amgen Inc (NASDAQ:AMGN) – Amgen submits U.S. application to sell cholesterol-fighting drug Company Update: Amgen Inc (NASDAQ:AMGN) – Amgen Announces Positive Top-Line Results From Second Phase 3 Study Of AMG 416 For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease Receiving Hemodialysis Stock Update: Amgen Inc (NASDAQ:AMGN) – Amgen Announces Webcast of 2014 Second Quarter Financial Results